NOVEN ANNOUNCES 2005 EARNINGS RELEASE DATE

Back

Miami, FL, February 23, 2006 -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the scheduled release date of its 2005 financial results.

On March 7, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter and year ended December 31, 2005. At 10:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same site. A taped replay of the call will be available beginning the afternoon of March 7 through March 9 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering account number 286 and conference ID number 193251.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are approved in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Back

Copyright ©  2006 Noven Pharmaceuticals, Inc. All rights reserved.